OAC
OMERS Administration Corp Portfolio holdings
AUM
$12.7B
1-Year Return
22.78%
This Quarter Return
+10.44%
1 Year Return
+22.78%
3 Year Return
+71.29%
5 Year Return
+144.31%
10 Year Return
+293.75%
AUM
$8.74B
AUM Growth
+$821M
(+10%)
Cap. Flow
+$229M
Cap. Flow
% of AUM
2.62%
Top 10 Holdings %
Top 10 Hldgs %
38.38%
Holding
529
New
236
Increased
28
Reduced
28
Closed
80
Top Buys
| 1 |
Waste Connections
WCN
|
$191M |
| 2 |
Lowe's Companies
LOW
|
$104M |
| 3 |
Broadcom
AVGO
|
$62.4M |
| 4 |
iShares Select Dividend ETF
DVY
|
$44.2M |
| 5 |
ERF
Enerplus Corporation
ERF
|
$34.6M |
Top Sells
| 1 |
Waste Management
WM
|
$161M |
| 2 |
TC Energy
TRP
|
$98.8M |
| 3 |
Yum China
YUMC
|
$19M |
| 4 |
GitLab
GTLB
|
$17.3M |
| 5 |
Microsoft
MSFT
|
$14.5M |
Sector Composition
| 1 | Technology | 21.18% |
| 2 | Financials | 19.07% |
| 3 | Industrials | 11.77% |
| 4 | Healthcare | 9.62% |
| 5 | Energy | 8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Abeona Therapeutics
ABEO
$353M
| $89.9K | ﹤0.01% |
+12,400
| New | +$89.9K |
|
327
Crexendo
CXDO
$199M
| $89.5K | ﹤0.01% |
+18,600
| New | +$89.5K |
|
328
Puma Biotechnology
PBYI
$253M
| $89K | ﹤0.01% |
+16,800
| New | +$89K |
|
329
Getty Images
GETY
$772M
| $88K | ﹤0.01% |
+21,200
| New | +$88K |
|
330
VTEX
VTEX
$744M
| $86.6K | ﹤0.01% |
+10,600
| New | +$86.6K |
|
|
HUYA
331
Huya Inc
HUYA
$796M
| $86.5K | ﹤0.01% |
+19,000
| New | +$86.5K |
|
332
Esperion Therapeutics
ESPR
$540M
| $86.3K | ﹤0.01% |
+32,200
| New | +$86.3K |
|
333
SSR Mining
SSRM
$4.28B
| $86K | ﹤0.01% |
19,300
-141,100
| -88% | -$629K |
|
334
The Honest Company
HNST
$446M
| $85.9K | ﹤0.01% |
+21,200
| New | +$85.9K |
|
335
Porch Group
PRCH
$1.9B
| $82.8K | ﹤0.01% |
+19,200
| New | +$82.8K |
|
336
Immersion
IMMR
$230M
| $81.5K | ﹤0.01% |
+10,900
| New | +$81.5K |
|
337
NN Inc
NNBR
$125M
| $81.5K | ﹤0.01% |
+17,200
| New | +$81.5K |
|
|
CTV
338
DELISTED
Innovid Corp.
CTV
| $80.7K | ﹤0.01% |
+32,400
| New | +$80.7K |
|
339
Taysha Gene Therapies
TSHA
$917M
| $80.4K | ﹤0.01% |
+28,000
| New | +$80.4K |
|
340
Absci
ABSI
$368M
| $79.5K | ﹤0.01% |
+14,000
| New | +$79.5K |
|
|
TE
341
T1 Energy Inc.
TE
$309M
| $78K | ﹤0.01% |
+46,400
| New | +$78K |
|
|
RDNW
342
RideNow Group, Inc. Class B Common Stock
RDNW
$150M
| $77.5K | ﹤0.01% |
+12,000
| New | +$77.5K |
|
343
CytomX Therapeutics
CTMX
$376M
| $77.2K | ﹤0.01% |
+35,400
| New | +$77.2K |
|
344
Gossamer Bio
GOSS
$668M
| $76.2K | ﹤0.01% |
+64,600
| New | +$76.2K |
|
345
Aquestive Therapeutics
AQST
$656M
| $74.1K | ﹤0.01% |
+17,400
| New | +$74.1K |
|
346
Cellectar Biosciences
CLRB
$15.9M
| $71.6K | ﹤0.01% |
+600
| New | +$71.6K |
|
347
The RealReal
REAL
$999M
| $71.2K | ﹤0.01% |
+18,200
| New | +$71.2K |
|
348
Werewolf Therapeutics
HOWL
$61.7M
| $70K | ﹤0.01% |
+10,800
| New | +$70K |
|
349
Wrap Technologies
WRAP
$86.9M
| $69.2K | ﹤0.01% |
+30,600
| New | +$69.2K |
|
350
Core Scientific
CORZ
$4.16B
| $68.7K | ﹤0.01% |
+19,400
| New | +$68.7K |
|